Show simple item record

dc.contributor.authorUsmani, Omar S
dc.contributor.authorKemppinen, Anu
dc.contributor.authorGardener, Elizabeth
dc.contributor.authorThomas, Vicky
dc.contributor.authorKonduru, Priyanka Raju
dc.contributor.authorCallan, Christina
dc.contributor.authorMcLoughlin, Andrew
dc.contributor.authorWoodhead, Vanessa
dc.contributor.authorBrady, Adam
dc.contributor.authorJuniper, Elizabeth F
dc.contributor.authorBarnes, Peter J
dc.contributor.authorPrice, David
dc.date.accessioned2018-03-26T23:02:15Z
dc.date.available2018-03-26T23:02:15Z
dc.date.issued2017-09
dc.identifier.citationUsmani , O S , Kemppinen , A , Gardener , E , Thomas , V , Konduru , P R , Callan , C , McLoughlin , A , Woodhead , V , Brady , A , Juniper , E F , Barnes , P J & Price , D 2017 , ' A Randomized Pragmatic Trial of Changing to and Stepping Down Fluticasone/Formoterol in Asthma ' , The journal of allergy and clinical immunology. In practice , vol. 5 , no. 5 , pp. 1378-1387.e5 . https://doi.org/10.1016/j.jaip.2017.02.006en
dc.identifier.issn2213-2201
dc.identifier.otherPURE: 100368334
dc.identifier.otherPURE UUID: 40c44bf1-8f21-4989-a031-b7d479ad3922
dc.identifier.otherPubMed: 28351782
dc.identifier.otherScopus: 85016022374
dc.identifier.urihttp://hdl.handle.net/2164/10241
dc.descriptionAcknowledgements We thank the study participants and the principal investigators and staff at the study sites for their contributions (listed in Table E7 in this article's Online Repository at www.jaci-inpractice.org). We are grateful to Optimum Patient Care Ltd research nurses Latife Hardaker, Miriam Cottle, Susanne Skinner, and Amanda Rosenberg and to Interface Clinical Services for site and patient recruitment and conduct of study clinics. We thank the Research in Real Life Ltd study team members Marjan Bojarnejad, Elwira Fidziukiewicz, Clare Fraser, Tahreem Sarwar, Cate Savage, and Natalie Tett for their support in the setup and conduct of the study and Clinical Studies lead Sandra Kreuzaler for study oversight. We also thank Alessandra Cifra for support with medical writing. MedDRA is owned by the International Federation of Pharmaceutical Manufacturers & Associations (IFPMA) on behalf of the International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH).en
dc.format.extent10
dc.language.isoeng
dc.relation.ispartofThe journal of allergy and clinical immunology. In practiceen
dc.rights© 2017. This manuscript version is made available under the CC-BY-NC-ND 4.0 license http://creativecommons.org/licenses/by-nc-nd/4.0/en
dc.subjectACQ7en
dc.subjectBiomarkersen
dc.subjectCombination therapyen
dc.subjectFluticasoneen
dc.subjectFormoterolen
dc.subjectFractional exhaled nitric oxideen
dc.subjectInhaled corticosteroidsen
dc.subjectPragmatic trialsen
dc.subjectSalmeterolen
dc.subjectStep-downen
dc.subjectAntiasthmatic agentsen
dc.subjectR Medicineen
dc.subjectMedicine(all)en
dc.subject.lccRen
dc.titleA Randomized Pragmatic Trial of Changing to and Stepping Down Fluticasone/Formoterol in Asthmaen
dc.typeJournal articleen
dc.contributor.institutionUniversity of Aberdeen.Other Applied Health Sciencesen
dc.contributor.institutionUniversity of Aberdeen.Institute of Applied Health Sciencesen
dc.description.statusPeer revieweden
dc.description.versionPostprinten
dc.identifier.doihttps://doi.org/10.1016/j.jaip.2017.02.006
dc.date.embargoedUntil2018-03-25


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record